NAV3 immunoreactivity is greatly enhanced in NFT-bearing pyramidal neurons in the cerebral cortex of AD brains, suggesting a compensatory response against NFT-generating neurodegenerative events in neurons. This evidence concerns the gene NAV3 and Alzheimer disease.